Tin tức & Cập nhật
Lọc theo Chuyên ngành:
TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients
20 Jan 2023
Tumour necrosis factor (TNF)-α antagonists show comparable safety as non-TNF biologics in the treatment of inflammatory bowel disease (IBD) in patients with active or recent cancer, as shown in a study.
TNFα antagonists, non-TNF biologics both safe for treating IBD in cancer patients
20 Jan 2023Ritlecitinib, brepocitinib superior to placebo for inducing remission in UC
13 Jan 2023
Ritlecitinib and brepocitinib as induction therapies for ulcerative colitis (UC) appear to be more effective than placebo while having an acceptable short-term safety profile, according to the results of a phase IIb study.